Obesity and severe COVID-19 study
Part of Hormones & metabolism, Infections, Lungs & breathing clinical trials.
This study looks at how obesity affects the body's response to severe COVID-19. It compares people with obesity to healthy-weight healthcare workers to understand differences in the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a BMI of 30 or higher, or a BMI under 25 for the control group.
- You are a patient or healthcare worker at Franciscus Hospital.
- You do not have an active infection or a long-term immune system disorder.
- You are not taking immune-modifying medications such as steroids or biologics.
- You are not on hormone therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This study looks at tiny particles released from fat tissue in people with and without obesity. It aims to understand differences that might help explain obesity-related health problems.
This study tests whether a behavioral (lifestyle) program can improve recovery from COVID-19, especially for Veterans with different body weights. It looks at people who either have never had COVID before or had COVID more than 90 days ago.
This study looks at hormone levels in people with severe obesity to understand how they differ from others. It may help explain how obesity affects the body.
This study looks at how obesity treatments work in real life for adults with a high body mass index. It aims to help doctors understand what works best for different people.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.